Cargando…
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
BACKGROUND: Novel circulating biomarkers may help in understanding the underlying mechanisms of atrial fibrillation (AF), a challenge for AF management and prevention of cardiovascular (CV) events. Whether glycosylation affects the prognostic value of N-terminal pro-B type natriuretic peptide (NT-pr...
Autores principales: | Staszewsky, Lidia, Meessen, Jennifer M. T. A., Novelli, Deborah, Wienhues-Thelen, Ursula-Henrike, Disertori, Marcello, Maggioni, Aldo P., Masson, Serge, Tognoni, Gianni, Franzosi, Maria Grazia, Lucci, Donata, Latini, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603582/ https://www.ncbi.nlm.nih.gov/pubmed/34798808 http://dx.doi.org/10.1186/s12872-021-02358-y |
Ejemplares similares
-
NT-proBNP: A Guide to Improve the Management of Patients with Heart Failure
por: Latini, Roberto, et al.
Publicado: (2014) -
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013) -
IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study
por: Meessen, Jennifer M. T. A., et al.
Publicado: (2021) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)